Browsing by Author Gil Gil, Miguel
Showing results 1 to 20 of 30
next >
| Issue Date | Title | Author(s) |
|---|---|---|
| 9-Jun-2020 | A Phase II Prospective, Randomized, Double‐Blind , Placebo‐Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor–Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting | Sánchez Rovira, Pedro; Lindén Hirschberg, Angelica; Gil Gil, Miguel; Bermejo de las Heras, Begoña; Nieto Magro, Concepción |
| 25-Jul-2023 | Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients | Pascual, Javier; Gil Gil, Miguel; Proszek, Paula; Zielinski, Christoph; Reay, Alistair; Ruíz Borrego, Manuel; Cutts, Rosalind; Ciruelos, Eva; Feber, Andrew; Muñoz Mateu, Montserrat; Swift, Claire; Bermejo, Begoña; Herranz, Jesús; Margelí Vila, Mireia; Antón, Antonio; Kahan, Zsuzsanna; Csöszi, Tibor; Liu, Yuan; Fernández García, Daniel; García Murillas, Isaac; Hubank, Michael; Turner, Nicholas C.; Martín, Miguel |
| 1-Nov-2018 | Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04) | Coleman, Robert E.; Collinson, M.; Gregory, W.; Marshall, Helen; Bell, Richard; Dodwell, David; Keane, Maccon; Gil Gil, Miguel; Barrett-Lee, Peter J.; Ritchie, Diana; Bowman, A.; Liversedge, V.; Boer, R. H. de; Passos Coelho, J. L.; O'Reilly, S.; Bertelli, G.; Joffe, J.; Brown, J. E.; Wilson, C.; Tercero, J. C.; Jean Mairet, J.; Gomis, R.; Cameron, David |
| 13-Oct-2011 | Breast-cancer Adjuvant Therapy With Zoledronic Acid | Coleman, Robert E.; Marshall, Helen; Cameron, David; Dodwell, David; Burkinshaw, Roger; Keane, Maccon; Gil Gil, Miguel; Houston, Stephen J.; Grieve, Robert J.; Barrett-Lee, Peter J.; Ritchie, Diana; Pugh, Julia; Gaunt, Claire; Rea, Una; Peterson, Jennifer; Davies, Claire; Hiley, Victoria; Gregory, Walter; Bell, Richard |
| 14-Apr-2023 | CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2−Metastatic Breast Cancer | Guerrero Zotano, Ángel; Belli, Stefania; Zielinski, Christoph; Gil Gil, Miguel; Fernández Serra, Antonio; Ruíz Borrego, Manuel; Ciruelos, Eva; Pascual, Javier; Muñoz Mateu, Montserrat; Bermejo, Begoña; Margeli Vila, Mireia; Antón, Antonio; Murillo, Laura; Nissenbaum, Bella; Liu, Yuan; Herranz, Jesús; Fernández García, Daniel; Caballero, Rosalía; López Guerrero, José Antonio; Bianco, Roberto; Formisano, Luigi; Turner, Nicholas; Martín, Miguel |
| 6-Mar-2024 | Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy | Pascual, Tomás; Fernández Martínez, Aranzazu; Agrawal, Yash; Pfefferle, Adam D.; Chic Ruché, Núria; Brasó Maristany, Fara; Gonzàlez-farré, Blanca; Paré, Laia; Villacampa, Guillermo; Saura, Cristina; Hernando, Cristina; Muñoz, Montserrat; Galván, Patricia; Gonzàlez Farré, Xavier; Oliveira, Mafalda; Gil Gil, Miguel; Ciruelos, Eva; Villagrasa, Patricia; Gavilá, Joaquín; Prat Aparicio, Aleix; Perou, Charles M. |
| 1-May-2020 | Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial | Lindén Hirschberg, Angelica; Sánchez Rovira, Pedro; Presa Lorite, Jesús; Campos Delgado, Míriam; Gil Gil, Miguel; Lidbrink, Elisabet; Suárez Almarza, Javier; Nieto Magro, Concepción |
| 24-Aug-2016 | Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients | Molina, David; Pérez Beteta, Julián; Martínez González, Alicia; Sepúlveda, Juan M.; Peralta, Sergi; Gil Gil, Miguel; Reynes, Gaspar; Herrero, Ana; Peñas, Ramón de las; Luque, Raquel; Capellades, Jaume; Balaña, Carmen; Pérez García, Víctor M. |
| 1-Oct-2021 | Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study | Kahan, Zsuzsanna; Gil Gil, Miguel; Ruiz Borrego, Manuel; Carrasco, Eva; Ciruelos, Eva; Muñoz Mateu, Montserrat; Bermejo, Begoña; Margeli, Mireia; Antón, Antonio; Casas, Maribel; Csöszi, Tibor; Murillo, Laura; Morales, Serafín; Calvo, Lourdes; Lang, Istvan; Alba, Emilio; Haba Rodriguez, Juan de la; Ramos, Manuel; Álvarez López, Isabel; Gal Yam, Einav; García Palomo, Andrés; Alvarez, Elena; González Santiago, Santiago; Rodríguez, César A.; Servitja, Sonia; Corsaro, Massimo; Rodrigálvarez, Graciela; Zielinski, Christoph; Martín, Miguel |
| 24-Jul-2020 | Immune Cell Associations with Cancer Risk | Palomero, Luis; Galvan Femenia, Ivan; Cid, Rafael de; Espín, Roderic; Barnes, Daniel R.; Blommaert, Eline; Gil Gil, Miguel; Falo Zamora, Catalina; Stradella, Agostina; Ouchi, Dan; Roso Llorach, Albert; Violan, Concepció; Peña Chilet, María; Dopazo, Joaquín; Extremera, Ana I.; Garcia Valero, Mar; Herranz, Carmen; Mateo González, Francesca; Mereu, Elisabetta; Beesley, Jonathan; Chenevix-Trench, Georgia; Roux, Cecilia; Mak, Tak; Brunet, Joan; Hakem, Razq; Gorrini, Chiara; Antoniou, Antonis C.; Lázaro García, Conxi; Pujana Genestar, M. Ángel |
| 9-Jul-2021 | Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study | Gil Gil, Miguel; Bellet Ezquerra, Meritxell; Bergamino Sirvén, Milana; Morales, Serafín; Barnadas, Agustí; Manso, Luis; Saura, Cristina; Fernández Ortega, Adela; Garcia Martinez, Elena; Martinez Jañez, Noelia; Melé, Mireia; Villagrasa, Patricia; Celiz, Pamela; Perez Martin, X.; Ciruelos, Eva; Pernas, Sònia |
| 9-Oct-2024 | Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial | Fullana, Bartomeu; Morales, Serafín; Petit, Anna; Alay, Ania; Verdaguer, Helena; Climent, Fina; Navarro Perez, Valentí; Cejuela, Mónica; Galvan, Patricia; Gumà, Anna; Llombart Cussac, Antonio; Cordero, David; Casanovas, Oriol; Prat Aparicio, Aleix; Gil Gil, Miguel; Pernas, Sonia |
| Oct-2021 | Organización y Calidad en el ámbito hospitalario | Barba Flores, María Ángeles; Codina Jané, Carles; Corbella, Xavier; Cossio Gil, Yolima; Cuadrado Benet, Sergi; Gamell Àlvarez, Lluís; García Montoya, Encarna; Gil Gil, Miguel; Gil Martin, Marta; González-Muñoz, Esther; Mangues i Bafalluy, Ma. Antònia; Ponce i Sebastià, Jordi; Rovira Lapiedra, Vicky; Sala de Vedruna, Gemma; Salazar Macián, Ramón; Salazar Soler, Albert; Salazar Soler, Ramón; Suñé i Negre, Josep M. (Josep Maria); Tabernero Caturla, Josep; Tomás Martínez, Esther; Vidal Milla, Ángel |
| 1-May-2019 | Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication | Bellet Ezquerra, Meritxell; Ahmad, Faten; Villanueva, Rafael; Valdivia, Carolina; Palomino Doza, Julián; Ruiz, Ada; Gonzalez-Farre, Xavier; Adrover, Encarna; Azaro, Analía; Valls Margarit, Maria; Parra, Josep Lluís; Aguilar Company, Juan; Vidal Losada, Maria Jesús; Martin, Anastasi; Gavilá, Joaquín; Escrivá de Romaní, Santiago; Perelló, Antonia; Hernando, Cristina; Lahuerta, Ainhara; Zamora, Pilar; Reyes, Victoria; Alcalde, María; Masanas, Helena; Celiz, Pamela; Ruiz, Isabel; Gil Gil, Miguel; Seguí, Miquel A.; Peña, Lorena de la |
| 1-Apr-2021 | Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL | Martin, M.; Zielinski, C.; Ruiz Borrego, M.; Carrasco, E.; Turner, N.; Ciruelos, Eva; Muñoz Mateu, Montserrat; Bermejo de las Heras, Begoña; Margelí Vila, Mireia; Anton, A.; Kahan, Z.; Csöszi, T.; Casas, M. I.; Murillo, L.; Morales, S.; Alba, Emilio; Gal Yam, E.; Guerrero Zotano, A.; Calvo, L.; Haba Rodríguez, J. de la; Ramos, M.; Álvarez López, Isabel; García Palomo, Andrés; Huang Bartlett, C.; Koehler, M.; Caballero, R.; Corsaro, M.; Huang, X.; García Sáenz, José Ángel; Chacón, José Ignacio; Swift, C.; Thallinger, C.; Gil Gil, Miguel |
| 27-Sep-2022 | Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial | Albanell Mestres, Joan; Pérez García, José Manuel; Gil Gil, Miguel; Curigliano, Giuseppe; Ruíz Borrego, Manuel; Comerma, Laura; Gibert, Joan; Bellet Ezquerra, Meritxell; Bermejo, Begoña; Calvo, Lourdes; Haba, Juan de la; Espinosa, Enrique; Minisini, Alessandro Marco; Quiroga Garcia, Vanesa; Santaballa Bertrán, Ana; Mina, Leonardo; Bellosillo Paricio, Beatriz; Rojo, Federico; Menéndez, Silvia; Sampayo Cordero, Miguel; Popa, Crina; Malfettone, Andrea; Cortés, Javier; Llombart Cussac, Antonio |
| 25-Sep-2019 | PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution | Pernas, Sònia; Petit, Anna; Climent, Fina; Paré, Laia; Perez Martin, J.; Ventura, Luz; Bergamino Sirvén, Milana; Galván, Patricia; Falo Zamora, Catalina; Morilla, Idoia; Fernandez Ortega, Adela; Stradella, Agostina; Rey, Montse; García Tejedor, María Amparo; Gil Gil, Miguel; Prat Aparicio, Aleix |
| 1-Dec-2017 | Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis | Martínez Aranda, Antonio; Hernández, Vanessa; Moreno, Ferran; Baixeras, Núria; Cuadras, Daniel; Urruticoechea Ribate, Ander; Gil Gil, Miguel; Vidal, Noemí; Andreu, Xavier; Seguí, Miquel A.; Ballester, Rosa; Castella, Eva; Sierra Jiménez, Àngels |
| 1-Dec-2016 | Preradiotherapy MR Imaging: A prospective pilot study of the usefulness of performing an MR examination shortly before radiation therapy in patients with glioblastoma | Majós Torró, Carlos; Cos, Mónica; Castañer, Sara; Pons Escoda, Albert; Gil Gil, Miguel; Fernández Coello, Alejandro; Macià, Miquel; Bruna, Jordi; Aguilera, Carlos |
| 6-Sep-2012 | Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a restrospective cohort study in Catalonia, Spain. | Font, Rebeca; Espinàs Piñol, Josep Alfons; Gil Gil, Miguel; Barnadas i Molins, Agustí; Ojeda, B.; Tusquets, Ignasi; Seguí, Miquel A.; Margelí Vila, Mireia; Arcusa, Angels; Prat Marín, Andrés; García, M.; Borràs Andrés, Josep Maria |